Globalworld globe
United Kingdom
North America
Europe
  • facebook
  • linkedin
Medical Developments International
  • Home
  • Products
    • Asthma & COPD
    • Penthrox
    • Medical Devices
    • Veterinary
  • About
    • Distributor Information
    • Careers
    • Associations
  • Investors/Media
    • Financial Reports
    • Board of Directors/Management
    • Corporate Governance
    • Media Centre
    • Diversity Policy
    • Share Trading Policy
  • Healthcare Professionals
  • Contact

News

Penthrox Launched in France and Belgium and first sales

Feb 7, 2017Mark EdwardsNews

8 February 2017

ASX ANNOUNCEMENT

Penthrox launched in France and Belgium and first sales.

Medical Developments International Limited (ASX: MVP) is delighted to announce Penthrox has been launched in both France and Belgium via its European partner, the Mundipharma network of independent associated companies (Mundipharma).

The ‘First Commercial Sale’ in France triggers a milestone payment of USD$2.0m to MVP which will be received within 30 days.

MVP CEO, Mr John Sharman, said: “The launch of Penthrox in France is an exciting achievement for MVP. France represents a significant market for Penthrox within Europe and pre-launch feedback from the market is extremely positive.”

Contact Us

for information on our range of products

Find a distributor

in our global network

Investors

invest in a company with
innovative foresight

News

  • Green Whistle gets the Green Light – FDA clears US Penthrox clinical trial

    2 March 2022 ASX ANNOUNCE...

  • MVP FY22 Half Year Results Investor Presentation

    25 February 2022 ASX anno...

  • MVP FY22 Half Year Report and Accounts

    24 February 2022 ASX Anno...

Healthcare Professional Registration

Login to access healthcare professional resources



Remember Me

Forgot password? | Register

Medical Developments International

Address:
4 Caribbean Drive, Scoresby,
Victoria, 3179
Australia
Phone: +61 3 9547 1888
Email: [email protected]
ABN: 14 106 340 667
For Medical Enquiries:

Phone: 1800 PENTHROX (1800 736 847)
Email: [email protected]

Email Newsletter